BIOTRICITY INC. Net Income Loss

• BIOTRICITY INC. showed an increase of +40.3% in Net Income Loss from 2024 to 2025.
• This data is from BIOTRICITY INC.'s annual report (Form 10-K), filed with the SEC on July 15, 2025.
• XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2015: -$1.23 million | Q4 2015: -$47.9 thousand | Q2 2016: -$1.04 million | Q3 2016: -$2.34 million | Q4 2016: -$2.62 million | Q2 2017: -$2.30 million | Q3 2017: -$1.45 million | Q4 2017: -$2.10 million | Q2 2018: -$2.42 million | Q3 2018: -$2.17 million | Q4 2018: -$2.17 million | Q2 2019: -$2.09 million | Q3 2019: -$2.01 million | Q4 2019: -$2.37 million | Q2 2020: -$3.16 million | Q3 2020: -$2.96 million | Q4 2020: -$3.90 million | Q2 2021: -$5.66 million | Q3 2021: -$10.75 million | Q4 2021: -$7.11 million | Q2 2022: -$4.78 million | Q3 2022: -$4.69 million | Q4 2022: -$4.52 million | Q2 2023: -$3.41 million | Q3 2023: -$3.69 million | Q4 2023: -$2.81 million | Q2 2024: -$3.69 million | Q3 2024: -$1.56 million | Q4 2024: -$1.23 million | Q2 2025: -$672.0 thousand | Q3 2025: -$690.9 thousand | Q4 2025: -$717.1 thousand.
• Over the full 13 years of available data (2014 to 2025), BIOTRICITY INC.'s Net Income Loss has declined by 9,146.7%.
• Historical annual values: Fiscal year 2025: -$8.42 million | Fiscal year 2024: -$14.09 million | Fiscal year 2023: -$18.66 million | Fiscal year 2022: -$29.13 million | Fiscal year 2021: -$15.49 million | Fiscal year 2020: -$11.07 million | Fiscal year 2019: -$8.59 million | Fiscal year 2018: -$8.62 million | Fiscal year 2017: -$7.81 million | Fiscal year 2016: -$7.28 million | Fiscal year 2015: -$5.19 million | Fiscal year 2015: -$90.8 thousand | Fiscal year 2014: -$91.1 thousand.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026